SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- HIV
An SI Board Since October 2004
Posts SubjectMarks Bans
155 12 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
105Patients and Doctors want meds which are effective without side-effects. ConcerElroy Jetson-8/14/2009
104Isentress is a fine drug, but it's a BID in a qD world.DewDiligence_on_SI-8/13/2009
103Bedtime story <b>Merck's AIDS Triumph</b> forbes.com Matthew idos-8/13/2009
102Nerve cells have natural resistance to HIV * 14:02 28 July 2009 by Andy Cogsim1-7/29/2009
101The New Battle Lines in HIV: siliconinvestor.comDewDiligence_on_SI-7/19/2009
100A potential breakthrough in HIV research and treatment: Contact: Danielle Viscidos-6/23/2009
99<b>A new path for HIV entry</b> the-scientist.com Posted by Edyta idos-5/19/2009
98Animal study Contact: Juliann Walsh Walshj1@email.chop.edu 267-426-6054 Childreidos15/18/2009
97Interesting stuff! Thanks for posting.DewDiligence_on_SI-4/24/2009
96Wed Apr 22 12:48:08 2009 (California Institute of Technology) <b>Caltech idos14/23/2009
95APRIL 16, 2009, 6:41 A.M. ET GlaxoSmithKline, Pfizer to Combine HIV Businesses kenhott-4/16/2009
94More on the controversial microbicide approach. This preclinical work suggests aidos-3/7/2009
93<b>HIV Adapts to ‘Escape’ Immune Response</b> main.uab.edu BIRidos-3/1/2009
92Hey, hey, now. This has been a very informative dialogue for me and I'm surtuck-2/22/2009
91There will always be a certain market for combination tablets, but I think this Elroy Jetson-2/21/2009
90Again, you ignore the matter of multiple copays for multiple tablets. Do you ackDewDiligence_on_SI-2/21/2009
89I have never met a patient who obtains different antivirals from different sourcElroy Jetson-2/21/2009
88Combination tablets can also create compliance problems. A frequent example is Elroy Jetson-2/21/2009
87When patients take multiple pills that must be taken in unison, what happens if DewDiligence_on_SI-2/21/2009
86The concept of "improved compliance" with a single tablet has been mucElroy Jetson-2/21/2009
85<i>>As the binding moiety of each drug is different, and the pathways bDewDiligence_on_SI-2/21/2009
84<i>Let me re-post this without the sentence which should not have been incElroy Jetson-2/21/2009
83As the binding moiety of each drug is different, and the pathways blocked can beElroy Jetson-2/21/2009
82<i>I believe GSK will combine IDX899 with the Epivir used in Epzicom, and DewDiligence_on_SI-2/21/2009
81I believe GSK will combine IDX899 with the Epivir used in Epzicom, and perhaps aElroy Jetson-2/21/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News